New Aspects for Treatment with Fosfomycin

Nonfiction, Health & Well Being, Medical, Specialties, Critical Care, Internal Medicine, General
Cover of the book New Aspects for Treatment with Fosfomycin by , Springer Vienna
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783709189030
Publisher: Springer Vienna Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783709189030
Publisher: Springer Vienna
Publication: December 6, 2012
Imprint: Springer
Language: English

Fosfomycin is an antimicrobial substance which is available since several years. In earlier clinical studies an oral preparation with poor absorption in a low dosage resulted in inadequate therapeutic results. The presently used parenteral administration in a dosage range of up to 250 mg/kg BW however allowed us to appreciate several unique properties of this drug which make it valuable in the treatment of serious bacterial infections. Due to its small molecular weight and complete lack of protein binding a favorable penetration in tissues and deep compartments (e.g., meninges, bone, heart valves) was observed. In addition fosfomycin shows a remarkably low toxicity and even protects from the nephrotoxigenic effects of aminoglycosides and other drugs. Earlier problems in antimicrobial susceptibility testing have been solved by addition of glucose 6 phosphate into the growth medium. Fosfomycin, the first representative of a completely new class of antibiotics does not show cross-resistance with other antibiotics; therefore pathogens of nosocomial infections, particularly methicillin- und gentamicin-resistant staphylococci are mostly susceptible to this antibiotic. Clinical investigations show a favorable therapeutic outcome in severe nosocomial infections despite of previous therapeutic approaches with various other potent antibiotics. In an international symposium in Mexico City the available clinical experience with this drug was presented and indications for the use of this antibiotic were established. Prof Dr. K. H. Spitzy Contents Summary-Zusammenfassung ......................................................... .

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Fosfomycin is an antimicrobial substance which is available since several years. In earlier clinical studies an oral preparation with poor absorption in a low dosage resulted in inadequate therapeutic results. The presently used parenteral administration in a dosage range of up to 250 mg/kg BW however allowed us to appreciate several unique properties of this drug which make it valuable in the treatment of serious bacterial infections. Due to its small molecular weight and complete lack of protein binding a favorable penetration in tissues and deep compartments (e.g., meninges, bone, heart valves) was observed. In addition fosfomycin shows a remarkably low toxicity and even protects from the nephrotoxigenic effects of aminoglycosides and other drugs. Earlier problems in antimicrobial susceptibility testing have been solved by addition of glucose 6 phosphate into the growth medium. Fosfomycin, the first representative of a completely new class of antibiotics does not show cross-resistance with other antibiotics; therefore pathogens of nosocomial infections, particularly methicillin- und gentamicin-resistant staphylococci are mostly susceptible to this antibiotic. Clinical investigations show a favorable therapeutic outcome in severe nosocomial infections despite of previous therapeutic approaches with various other potent antibiotics. In an international symposium in Mexico City the available clinical experience with this drug was presented and indications for the use of this antibiotic were established. Prof Dr. K. H. Spitzy Contents Summary-Zusammenfassung ......................................................... .

More books from Springer Vienna

Cover of the book Advances and Technical Standards in Neurosurgery by
Cover of the book Ion Beams in Materials Processing and Analysis by
Cover of the book Cervical Spine II by
Cover of the book Knee Arthroplasty by
Cover of the book Risk Control and Quality Management in Neurosurgery by
Cover of the book Immersive Projection Technology and Virtual Environments 2001 by
Cover of the book Advances and Technical Standards in Neurosurgery by
Cover of the book Anticarbohydrate Antibodies by
Cover of the book Advances in Epilepsy Surgery and Radiosurgery by
Cover of the book Advances in Stereotactic and Functional Neurosurgery 9 by
Cover of the book Understanding the Neurotransmitters: Key to the Workings of the Brain by
Cover of the book Psychiatric Drugs in Children and Adolescents by
Cover of the book Thoracic and Lumbar Spine and Spinal Cord Injuries by
Cover of the book Dynamics of the Singing Voice by
Cover of the book Prevention and Treatment of Delayed Ischaemic Dysfunction in Patients with Subarachnoid Haemorrhage by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy